Table 1.
Association between clinicopathological characteristics and LEA expression
| LEA expression | χ2 | Spearman's correlation | ||||
|---|---|---|---|---|---|---|
| n (%) | Negative 5 (5.6) | Weak‐moderate 60 (67.4) | Strong 24 (27.0) | P‐value | r | P‐value |
| Age | 0.571 | ‐0.054 | 0.616 | |||
| ≤60 | 2 (40.0) | 17 (28.3) | 9 (37.5) | |||
| >60 | 3 (60.0) | 43 (71.7) | 15 (62.5) | |||
| Gender | 0.620 | ‐0.043 | 0.692 | |||
| Female | 3 (60.0) | 27 (45.0) | 13 (54.2) | |||
| Male | 2 (40.0) | 33 (55.0) | 11 (45.8) | |||
| Tumor size (cm) | 0.671 | ‐0.035 | 0.749 | |||
| ≤5 | 1 (20.0) | 27 (45.0) | 10 (41.7) | |||
| >5 | 4 (80.0) | 33 (55.0) | 14 (58.3) | |||
| Histology | 1.000 | 0.053 | 0.622 | |||
| Adenocarcinoma | 5 (100.0) | 53 (88.3) | 21 (87.5) | |||
| Mucinous carcinoma | 0 | 5 (8.4) | 2 (8.3) | |||
| Others | 0 | 2 (3.3) | 1 (4.2) | |||
| T stage | 0.012 a | 0.270 | 0.010 a | |||
| T1‐2 | 3 (60.0) | 9 (15.0) | 1 (4.2) | |||
| T3‐4 | 2 (40.0) | 51 (85.0) | 23 (95.8) | |||
| N stage | 0.931 | 0.021 | 0.847 | |||
| N0 | 3 (60.0) | 40 (66.7) | 15 (62.5) | |||
| N1‐2 | 2 (40.0) | 20 (33.3) | 9 (37.5) | |||
| M stage | 1.000 | 0.040 | 0.711 | |||
| M0 | 5 (100.0) | 58 (96.7) | 23 (95.8) | |||
| M1 | 0 | 2 (3.3) | 1 (4.2) | |||
a
P < 0.05 indicates a statistically significant difference.